Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Multiple-Dose Study of TK-002 in Healthy Adult Men
jRCT2031260441Phase 1Recruiting
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial comparing TK-002 arm with Placebo arm (2 arms). Primary endpoints: Safety and Plasma drug concentration. Started Sep 2026; status: recruiting.
02
Drugs
TK-002
Beyond the preview
Go deeper on jRCT2031260441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260441.